Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review Paul de BoissieuL. KanagaratnamT. Trenque Review 10 February 2017 Pages: 517 - 523
Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials Luis E. Simental-MendíaMario Simental-MendíaFernando Guerrero-Romero Review 09 February 2017 Pages: 525 - 536
Pharmacokinetics of ginkgolides A, B and K after single and multiple intravenous infusions and their interactions with midazolam in healthy Chinese male subjects Feng ShaoHongwen ZhangWei Xiao Clinical Trial 20 January 2017 Pages: 537 - 546
Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects Yue-Qi LiZheng-Yu YanYong-Qing Wang Clinical Trial 31 January 2017 Pages: 547 - 554
Pharmacokinetics of a new, nasal formulation of naloxone Ida TylleskarArne Kristian SkulbergOla Dale Pharmacokinetics and Disposition 31 January 2017 Pages: 555 - 562
Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment Marina SenekSten-Magnus AquiloniusDag Nyholm Pharmacokinetics and Disposition Open access 18 January 2017 Pages: 563 - 571
High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury M. A. SikmaC. C. HunaultJ. Meulenbelt Pharmacokinetics and Disposition Open access 28 January 2017 Pages: 573 - 580
First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases Eric HelmerMark WatlingEugene Healy Pharmacokinetics and Disposition Open access 04 February 2017 Pages: 581 - 591
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel William L. MarshallHwa-Ping FengWendy W. Yeh Pharmacokinetics and Disposition 24 February 2017 Pages: 593 - 600
Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France Marie HerrHelene GrondinJoël Ankri Pharmacoepidemiology and Prescription 16 January 2017 Pages: 601 - 608
Off-label use of antimicrobials in neonates in a tertiary children’s hospital Niina LaineAnn Marie KaukonenHarri Saxen Pharmacoepidemiology and Prescription 18 January 2017 Pages: 609 - 614
Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults Mariana Martins Gonzaga do NascimentoJuliana Vaz de Melo MambriniAntônio Ignácio de Loyola Filho Pharmacoepidemiology and Prescription 20 January 2017 Pages: 615 - 621
Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres Linda Amundstuen ReppeOlav SpigsetJan Schjøtt Pharmacoepidemiology and Prescription Open access 05 February 2017 Pages: 623 - 631
Definition of variables required for comprehensive description of drug dosage and clinical pharmacokinetics Anna v. MedemHanna M. SeidlingWalter E. Haefeli Pharmacoepidemiology and Prescription 14 February 2017 Pages: 633 - 641
Contextualizing patient care: opportunities for pharmacotherapy education David J. BrinkmanJelle TichelaarMichiel A. van Agtmael Letter to the Editor 20 January 2017 Pages: 643 - 644
Intravenous methylprednisolone induced acute pancreatitis N YahiaouiM RocheM Mallaret Letter to the Editor 28 January 2017 Pages: 645 - 646
Valproic acid—induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report Pavla PokornáKarolina HronováDick Tibboel Letter to the Editor 06 February 2017 Pages: 647 - 649